Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.605 USD | +3.59% | +2.92% | +112.65% |
30/05 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
07/05 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+112.65% | 33Cr | |
+18.79% | 13TCr | |
+13.49% | 11TCr | |
-4.55% | 2.46TCr | |
+3.35% | 2.28TCr | |
-11.30% | 1.82TCr | |
-41.48% | 1.65TCr | |
-13.04% | 1.65TCr | |
+1.35% | 1.34TCr | |
+21.16% | 1.11TCr |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- ADC Therapeutics Q1 Loss Narrows, Names New CEO; Shares Sink